Menumenu
  • slide

    Current practice insights into the use of biologicals

  • slide

    Rapid access to our in-house patient-centric Database Network

  • slide

    An experienced sparring partner for your European healthcare questions

  • slide

    Dedicated to research real-life health care for the benefit of patients

  • News

    Annual scientific report 2016 online!

    PHARMO's annual scientific report discusses the current expertise and research of the PHARMO Institute, publications, international collaborations and partners. Furthermore the annual report describes the organisational structure and information on h...

    Differences in treatment patterns for type 2 diabetes in Europe after similar initial treatment

    Metformin is the most common initial type 2 diabetes (T2DM) treatment in the Netherlands, Italy, Spain, France, and the United Kingdom, but second- and next-line treatments differ per country. Differences are especially seen regarding the uptake of n...

    Press release: Forced switch Thyrax leads to problems (Dutch only)

    Research confirms: concerns were justified Today the results of the study into the consequences of switching from Thyrax to other brands of levothyroxine were published. Last year, 350.000 patients who used Thyrax were forced to switch to other br...

  • Events

    Meet us at ISPOR in Glasgow!

    Meet us at the ISPOR 20th Annual European Congress in Glasgow, Scotland The PHARMO team will be present at the 20th Annual European Congress in Glasgow, Scotland, November 4-8, 2017. We are pleased to announce that we will present our work in t...

    PHARMO at ICPE Montreal!

    The PHARMO team had a great time at ICPE Montreal! It was good to meet all the experts in the field, (re)connect with our clients and exchange ideas about the PHARMO Database Network and our expertise in pharmacoepidemiology and drug outcomes resea...

    Insight into the use and indication of drugs: a pilot study in patients with colon or rectal cancer
    Presentation at the Dutch Hospital Pharmacy days 2016

    Josine Kuiper, our oncology expert researcher, presented the first results of the Rx-pilot that provides insight into the use and outcomes of medicines in hospitals. Her presentation was held at the Dutch hospital pharmacy conference 2016. The pilot ...

    PHARMO won ‘Best in stream’ award at PhUSE Annual Conference, Barcelona 9th-12th October 2016

    Edith Heintjes won the ‘Best in stream’ award with her presentation ‘Real-world evidence: a comparison between countries: common data models and SAS catalogs’ in the RWE stream at this year’s Pharmaceutical Users Software Exchange meeting. ...

  • Vacancy

    No vacancies

    True to our mission to excel in the interests of improving patient treatment and care, we operate in an entrepreneurial and multidisciplinary environment. The specialists we recruit are from various backgrounds, including: epidemiologists, pharmacist...

  • icon

    What we do

    As an independent research organisation dedicated to the study of epidemiology, drug utilisation, drug safety, health outcomes, and utilisation of healthcare resources PHARMO assists its clients in their decision-making.

  • icon

    What we have

    PHARMO Database Network: we have rapid access to our rich population-based network of databases. Data are derived from different primary and secondary healthcare settings. For our observational studies disease-specific cohorts are created from the various databases.

Publications

  • No decreased risk of gastrointestinal cancers in users of metformin in The Netherlands; a time-varying analysis of metformin exposure

    Read more
  • Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner data

    Read more
  • No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study

    Read more
  • Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes

    Read more